tiprankstipranks
Trending News
More News >
Vertex Pharmaceuticals Inc. (DE:VX1)
:VX1

Vertex Pharmaceuticals (VX1) Similar Stocks

Compare
23 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Vertex Pharmaceuticals
€387.25
€98.82B
30.33
2.66%
16 Buy
6 Hold
0 Sell
Moderate Buy
Alnylam Pharma
$400.23
$52.88B
1,664.85
63.07%
17 Buy
4 Hold
0 Sell
Strong Buy
Incyte
$102.69
$20.16B
17.23
49.17%
9 Buy
8 Hold
1 Sell
Moderate Buy
Regeneron
$767.96
$80.71B
18.39
9.03%
16 Buy
6 Hold
1 Sell
Moderate Buy
Argenx Se
$854.99
$53.06B
40.16
36.57%
17 Buy
3 Hold
0 Sell
Strong Buy
BioNTech SE
$92.50
$22.24B
-35.16
-18.20%
12 Buy
3 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:VX1
Vertex Pharmaceuticals
387.25
10.05
2.66%
ALNY
Alnylam Pharma
400.23
154.79
63.07%
INCY
Incyte
102.69
33.85
49.17%
REGN
Regeneron
767.96
69.98
10.03%
ARGX
Argenx Se
854.99
231.17
37.06%
BNTX
BioNTech SE
92.50
-20.58
-18.20%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts